# Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma

> **NCT01199718** · PHASE1 · UNKNOWN · sponsor: **Cylene Pharmaceuticals** · enrollment: 22 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** CX-4945

## Key facts

- **NCT ID:** NCT01199718
- **Lead sponsor:** Cylene Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2011-06
- **Final completion:** 2011-09
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2011-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01199718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01199718, "Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01199718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*